Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiopericytoma, Malignant × vatalanib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Glioblastoma 3 Central Nervous System Neoplasms 3 Gliosarcoma 2 Brain Neoplasms 2 Sarcoma 1 Oligodendroglioma 1 Meningioma 1 Hemangiopericytoma, Malignant 1 Glioma 1 Ependymoma 1 Astrocytoma 1

Interventions

vatalanib 1 Trabectedin 1 Magnetic Resonance Spectroscopy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00348790 2018-10-26

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Northwestern University

Phase 2 Completed

25 enrolled 10 charts

Hemangiopericytoma, Malignant, Brain Neoplasms, Meningioma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡